Concern has been expressed in the profession about environmental contamination from products used in companion animal treatment for ectoparasites, such as fleas and ticks.
In recent years there has been a widely documented fall in the abundance of many terrestrial invertebrate populations1.
While the decline has been mostly linked to agricultural chemicals, there is a concern that companion animal ectoparasiticides could also be a contributing factor, with a recent study2 confirming the presence of common compounds used in flea-treatment3 in UK waterways.
However, the association with companion animal ectoparasiticides is currently poorly understood, with a significant knowledge gap and little robust research available to assess the true importance and environmental consequences.
The funded project ‘Assessing the Environmental Risk from Ectoparasite Treatments in Companion Animals’ will be led by Professor Richard Wall, Professor of Zoology and Dr Emily Bell, Senior Lecturer at University of Bristol in collaboration with Dr Imogen Schofield, Veterinary Statistician and Epidemiologist at CVS, and Lizzie McLennan-Green, Small Animal Veterinary Director at CVS.
It will be conducted via a PhD studentship at the University of Bristol as part of the CVS Clinical Research Awards.
The research will include a longitudinal ‘citizen science’ study with pet owners to develop a greater understanding of owner use and attitudes towards ectoparasiticides.
It will also include laboratory assessments of ectoparasiticide residues collected from companion animals to provide evidence-based information on the potential environmental impact of the treatments when applied to companion animals.
It is hoped the study will help the wider veterinary profession develop the most appropriate approaches to prescribing and use of ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’. The study is also set to benefit companion animals, as the research will inform strategies to ensure the most appropriate control of parasitic burden to pets.
The project starts in January 2023 and will run for three-years as a full time PhD.
CVS is providing £95,000 to fund the research.
References
The surgery was carried out in August 2018 and is, they say, the first time it has been performed on a companion animal anywhere in the world. The dog, a five-year old spaniel called Gigha, has now made a full recovery.
Gigha’s surgery was carried out by Dr Guy Killick and featured in a recent episode of The Yorkshire Vet. Guy said: "Gigha provides vital companionship to her owner, Mrs Taylor. She fell into a drainage ditch last summer and this caused a tiny cut on her elbow.
"The initial wound did not seem severe, however, despite intensive decontamination and treatment with broad spectrum antibiotics, the wound proved to have been infected with a resistant Haemolytic E. coli infection, causing a significant loss of skin from the medial aspect of the elbow. During this time, Gigha was hospitalised and was at significant risk of DIC and septicaemia."
"The skin loss was full thickness and, once the compromised tissue was debrided away, she was left with a large wound.
"We managed the wound in hospital for four days with daily dressing changes and an irrigation device to provide local anaesthesia and the delivery of topical antibiotics.
"Unfortunately, skin grafting in her case was not suitable given the infection and a lack of sufficient loose skin to donate. As such, we elected for healing by second intention but, given the large area, we felt it was important to explore novel methods to accelerate the healing process and reduce Gigha’s pain.
"Surgery using Tilapia fish skin grafts was pioneered at UC Davis in the USA and was used successfully on a horse with acid burns in the UK last year. It is still very rare, however, and had not been used to treat an infected wound before. Nor had it been used on a dog.
"Having done our research though and finding that these grafts have a natural anti-infective and analgesic effect, while also reducing the frequency of bandage changes that would cause discomfort and distress to the patient, we felt it was an appropriate treatment for Gigha and carried out the surgery a week after the initial wound."
Guy says the surgery was straightforward and simply involved tacking the skin in place. It adhered to the developing granulation bed, accelerating its growth and providing an antiseptic and analgesic effect. After application, Gigha’s owner reported that she was much brighter and seemed to be in less pain. Pain-scoring during check-ups confirmed this to be the case despite pain relief being voluntarily withdrawn by the owner.
This initial graft stayed in place for two weeks before breaking down and being removed. By this stage, granulation of the wound had been completed and around one cm of neo-epithelisation had occurred. A further graft was then placed which remained for a further two weeks until the wound was 50% of its initial size. No further grafts were placed as the team did not have access to further supplies so they simply bandaged the wound with traditional bandages. It was completely healed within nine weeks. Eight months on, Gigha has made a full recovery and the wound has healed completely.
Guy said: "Given the large wound area and risk of further infection we decided on this novel approach to improve the quality of life for the patient while the wound was healing. While we were naturally apprehensive of making the first attempt at this potentially revolutionary technique, what we knew about fish skin grafts and suggested that they could work in her case so we were determined to give it a try.
"Looking at her now, you wouldn’t believe that she’d been days from death just a few months ago. Her case is a demonstration of the efficacy of fish skin grafts as a treatment for large wounds where there are no other suitable methods of closure – and for their use in dogs. We hope her story and her recovery will be useful to colleagues treating dogs with similar wounds in the future and are happy to discuss the case with them if this would be helpful.
"I would also like to thank Dr Jamie Peyton, Chief of Integrative Medicine Service at UC Davis for her invaluable help and advice during this case and her assistance in the use of the Tilapia graft."
For the study, Luisa De Risio, clinical research and excellence director at Linnaeus and a co-investigator, is collaborating with neurology specialists and primary care vets at Linnaeus practices to recruit cases.
Luisa said: “Canine idiopathic epilepsy is a disease that is common in many breeds of dog and can significantly impact the quality of life of both affected dogs and their owners.
"However, there is limited knowledge concerning the role of genetic factors in susceptibility to the disease in most breeds.
“The overarching aim of this large-scale collaborative study is to identify the genetic factors contributing to the risk of developing idiopathic epilepsy as this could help develop tools to lower the incidence of the condition in future generations.
“The study will initially focus on the Border Collie and Italian Spinone, as they can suffer from a particularly severe and life-limiting form of epilepsy, before expanding the study to other breeds in the future.
Dr Sally Ricketts, the geneticist leading the study at the Kennel Club Genetics Centre in the Department of Veterinary Medicine at the University of Cambridge, said: “We are very excited about this collaboration, which will facilitate our sample collections to enable study of this debilitating disease.
For more information on the study, visit www.canine-genetics.org.uk/research/epilepsy.
Photo: Sally Ricketts, senior research associate at the Kennel Club Genetics Centre, Department of Veterinary Medicine, University of Cambridge; Luisa De Risio, clinical research and excellence director at Linnaeus and Christopher Jenkins, research assistant at the Kennel Club Genetics Centre, Department of Veterinary Medicine, University of Cambridge.
Mr Molnar had been convicted at Manchester and Salford Magistrates’ Court in March 2018 of five counts of importing puppies to the UK in contravention of the Rabies (Importation of Dogs, Cats and other Mammals) Order 1974.
At that court hearing he also pleaded guilty to one count of keeping premises as a pet shop without the authority of a licence granted by a local authority.
As a result of his conviction Mr Molnar was sentenced to 270 hours of unpaid supervised work and was ordered to pay compensation of £2,683.93 and costs of £250.
The Committee, which proceeded with the hearing in Mr Molnar’s absence, found that the RCVS charges against Mr Molnar were proven and went on to consider whether, individually and cumulatively, they resulted in Mr Molnar being unfit to practice being a veterinary surgeon.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee accepts the College’s submission that the fact that they [the puppies] were imported contrary to the law of the UK, because they were underage and had not been properly vaccinated, undermines the integrity of a system which is designed to ensure that effective vaccination and precautions against disease take place in every case.
"The Committee also notes that the convictions in this case were directly linked to the respondent’s veterinary practice, as they related to animals sold from his veterinary practice address. By operating an unlicensed pet shop, and by doing so through an email address that referred to his occupation as a veterinary surgeon, the respondent was abusing his position as a veterinary surgeon, and acting in a way that was liable to undermine the reputation of the profession."
The Committee therefore found that, because Mr Molnar’s conviction was directly linked to his veterinary practice and posed a substantial risk to animal welfare and public health, his conviction meant his conduct fell far short of what was expected of a professional.
In considering the sanction for Mr Molnar the Committee considered that, while he had no previous convictions or adverse professional findings against him, the case against him was very serious "because of the risk of serious harm both to animals and the public, as well as being for financial gain."
Ian Green said: "The Committee considered that the respondent, as a veterinary surgeon, must have known the serious implications and consequences of what he was doing by importing these puppies unlawfully. The public should expect to be able to trust a veterinary surgeon to ensure that his conduct does not put at risk the health of both animals and humans."
Mr Green added that the Committee felt that the only appropriate sanction was to direct the Registrar to remove Mr Molnar’s name from the Register.
Vetoquinol has announced the introduction of Melovem to the UK market. Melovem is a new injectable preparation containing 5mg/ml meloxicam which is licensed for use in pigs and young cattle.
According to the company, meloxicam is the most widely used veterinary non steroidal anti-inflammatory injection in the UK. Presented in 100ml bottles, with a lower dose formulation, Melovem can be a cost-effective NSAID solution to leave on-farm.
Mark Leddy from Vetoquinol said: "We are pleased to be the distributors of Melovem in the UK. Melovem provides vets and farmers with a new, cost-effective meloxicam injection that is suitable for on-farm use."
Contact your Vetoquinol representative for more information on Melovem, or call Vetoquinol on 0800 1608197.
For the study, which was funded by the charity Songbird Survival, researchers collected the nests of 103 blue and great tits, and tested them for the presence of 20 insecticides.
Fipronil, imidacloprid and permethrin were the main culprits, detected in 100%, 89.1% and 89.1% of the samples respectively.
Overall, a higher number of either dead offspring or unhatched eggs was found in nests containing a higher number of insecticides, higher total concentration of insecticides or a higher concentration of fipronil, imidacloprid or permethrin, which the authors say suggests contact exposure of eggs to insecticides in nest lining may lead to mortality and lower reproductive success.
The BVA responded by calling for more research and encouraging vets to work with clients to ensure responsible use of parasiticides.
BVA President Elizabeth Mullineaux said: “Parasiticides play an important role in preventing and treating parasites in animals, which if left unaddressed can lead to bigger health and welfare issues in both animals and people.
"But it’s important they are used responsibly, and this work from the University of Sussex and SongBird Survival highlights the need for more research into how parasiticides affect the environment and wildlife and the associated risks.
“Rather than blanket use, we strongly encourage vets and owners to take a risk-based approach to prescribing or recommending these medicines, reflecting an animal’s exposure to parasites."
Reference
RSA has confirmed the initial 27 practices that have joined its new Preferred Referral Network, launching today.
The creation of the network means that whilst veterinary surgeons can continue to appoint referral practices as they do now, owners of animals needing a non-emergency referral outside the RSA network may need to pay £200 towards the cost of treatment.
The new rules currently apply to holders of policies issued by Tesco Bank and MORE TH>N, however RSA says it is in discussion with other insurance brands about adopting the new network.
RSA says the Preferred Referral Network will enable it to provide competitively priced products and deliver a range of benefits for customers including:
The company is highlighting the fact that its new network fields 178 RCVS, EBVS or AVMA recognised specialists, 49 Diploma holders and 71 Certificate holders or Advanced Practitioners, working at a mixture of large, multi-disciplinary centres (including five with links to university teaching hospitals), independents and corporates.
RSA says that over the last 12 months, vets have directed more than half of all RSA cases to the 27 practices in its network.
Bill Paton, Claims Director for UK and Western Europe said: “We are delighted to have twenty seven practices from around the UK join our preferred referral network. This is a huge step forward and will enable us to continue to provide competitively priced insurance cover with access to the highest standards of veterinary treatment and care.
"We expect further practices to join the Network in due course and we are actively engaged in discussions with a number of referral practices of varying size and scale, which have expressed an interest in joining."
The 27 referral practices are:
South East
South West
Midlands
North West
North East
East
Scotland
* referral arrangements still being finalised
The survey, which received 2445 responses from BVA members, found that 16% of vets and vet students have personally experienced discrimination within a veterinary workplace or learning environment in the past twelve months, while 20% had witnessed discrimination.
Senior colleagues were most commonly responsible for the discrimination (47% of incidents), with discrimination from clients accounting for 35% of incidents.
Sex discrimination was the most common type reported (44% of incidents) and was particularly prevalent in academic settings and in production animal, equine, and mixed practices.
Race discrimination was the next most commonly reported (27% of incidents).
Respondents also gave details of discrimination in relation to other protected characteristics, including age, sexuality, disability and gender reassignment.
Younger vets were more likely than older vets to have personally experienced discrimination in the past year (27% of those under 35 had experienced discrimination).
Female vets were more than twice as likely to have experienced discrimination than their male colleagues (19% and 8% respectively).
The incidence of discrimination was higher amongst vets from a range of minority ethnic backgrounds. Those who described their sexual orientation as bi, gay or lesbian were twice as likely to have personally experienced discrimination in the past year.
Despite the high incidence of discrimination reported, responses to the same survey showed that only 56% of the profession feel concerned about discrimination.
British Veterinary Association Junior Vice President Daniella Dos Santos (pictured right) said: "This is the first time anyone has collected such a significant body of evidence on this issue and the results are truly shocking. It is completely unacceptable that so many members of the veterinary team are subject to discrimination not just from clients but from members of our own profession.
"Worryingly, it seems that the scale of the issue will come as a surprise to many members of our profession and so it is vital that we all join the conversation and reflect on what role we can play to improve equality and inclusion. The veterinary team must become a safe and supportive environment for everyone. We cannot accept anything less for ourselves, for our colleagues and for our profession."
Only 12% of respondents were satisfied with how their incident had been dealt, rising to 23% among those who felt able to report. Daniella said: "Many of the experiences documented in our report are shocking and distressing and this distress is often compounded by what comes next. It was very saddening to hear that so many people have felt unable to report their experiences or that their reports were handled badly by those who received them.
"Experiencing discrimination can be very traumatic, without the ‘double-whammy’ of having your complaint dismissed or mishandled by managers or senior staff. We need to make sure everyone who experiences discrimination is able to get the outcome they deserve.
"Through the discrimination questionnaire we heard many distressing stories from vets, students, vet nurses and other colleagues. We are incredibly grateful to them for sharing these with us so that we can raise awareness of what’s happening in our veterinary workplaces."
To raise awareness of the scale of the issue, the BVA is inviting all members of the veterinary team to join a "Big Conversation on equality and inclusion in the veterinary professions", starting with the release of its report on the current situation on discrimination, which can be downloaded here, then inviting everyone to join online engagement sessions through social media and BVA members to feed in views via their regional representatives ahead of Council on 24 July.
The company says that of the 249 responses to its Puppy Tooth Census received so far (of which 40% were from vets, 21% vet nurses, 2% other veterinary professionals and 37% puppy owners), 25% were poodle crosses.
This, says the company, is in line with anecdotal reports that vets are seeing more dental conditions in poodle cross puppies.
VisioCare is now calling for more vets to take part in the survey at https://bit.ly/Visiocare_PuppyToothCensus.
With very few studies that address dental disease in puppies and a lack of current data, it is hoped that the survey will advance understanding and improve oral health and welfare.
Every veterinary respondent will be given access to a pack of educational materials to use in the consulting room, including digital animations and dental images that can be used to enhance client communication around the topic, together with explainer videos and puppy owner fact sheets and leaflets.
In addition, each month for the next three months, all responses will be entered into a prize draw for the chance to win a £50 John Lewis gift voucher.
VisioCare is also offering a free webinar: "Challenges in Puppy Dentistry and Malocclusion" presented by Ingrid Tundo, Head of the Dentistry and Oral Surgery Department at the Royal (Dick) Vet School, viewable at: https://veterinarywebinars.com/register/puppy-dentistry-malocclusion.
Finally, Nicky Diver-Clarke, Marketing Manager at VisioCare Services is also offering a free marketing CPD session for practices that want to find the best way to amplify awareness of the Puppy Tooth Census within their practice.
Anyone interested in accessing the free support can contact her at nicky@visiocareservices.co.uk.
Hot on the heels of Eurovet, Ceva Animal Health has launched Emeprid, containing the anti-emetic and pro-kinetic metoclopramide. Emeprid is licensed in cats and dogs for the symptomatic treatment of vomiting and reduced gastro-intestinal motility associated with gastritis, pyloric spasm, chronic nephritis and digestive intolerance to some drugs.
There are two formulations available; a 10ml multi-dose vial containing 5mg/ml metoclopramide for IV, SC or IM injection and a 125ml 'sweet orange and apricot flavoured' oral solution containing 1mg/ml metoclopramide. They are priced at £7.99 for the 10ml injectable bottle and £9.99 for the oral solution.
For further information, please contact your Ceva Animal Health representative or call the veterinary support team on 01494 781510.
Christine will take over from Nigel Gibbens who is stepping down at the end of February 2018 after 10 years in the post.
Christine, who comes from a farming family in the south of Scotland, is an experienced veterinary surgeon who worked for a number of years in private practice in Scotland and the north of England, prior to joining the Animal Health agency (now part of the Animal and Plant Health Agency) in 2008 as a Divisional Veterinary Manager in Scotland.
Since 2016, she has been working as the CVO in New South Wales, Australia, where she has led major improvements to biosecurity across many farming sectors.
Christine said: "I am delighted to have been appointed and it will be a privilege to lead my veterinary colleagues to support our farming and food industry in this hugely important role.
"I am very much looking forward to working again with the team at Defra, its agencies, the devolved administrations and all the individuals and groups which will contribute to meet future challenges across animal health and welfare.
"The UK Government has made no secret it wants to cement its place as a world-leader on animal welfare as they leave the European Union, and I’m delighted to have an opportunity to play a part in that."
Nigel said: "I would like to congratulate Christine on her success against a strong field of candidates and I am certain she will be a great addition to the department.
"Her breadth of experience from work within Government and in the private sector will enable her to provide excellent veterinary leadership to the Defra group to deliver government’s ongoing commitment to maintaining our high animal health and welfare standards and to represent the interests of the whole of the UK internationally."
Animal Welfare Minister Lord Gardiner added: "I warmly welcome Christine to her important role. She brings to it a wealth of experience and enthusiasm.
"This Government is embarking on an ambitious programme of animal welfare reform, including plans to increase the maximum sentence for animal cruelty to five years in prison and introducing mandatory CCTV in all abattoirs. Christine will be invaluable in helping us in achieving world leading standards.
"I thank Nigel Gibbens for his outstanding contribution as CVO over the past ten years. Leaving the department at the end of February, he is hugely respected across the veterinary community and beyond – leading on responses to disease outbreaks including avian influenza and advising government on issues from antimicrobial resistance to animal welfare."
British Veterinary Association President John Fishwick said: "We’d like to congratulate Christine Middlemiss on her appointment as the UK’s next CVO and welcome her return to Defra - as well as to the UK, following her 16 months as CVO in New South Wales, Australia.
"As Christine notes, she will take up her role amidst EU Exit negotiations when the vital role veterinary surgeons play in so many areas of political and public life must be championed and considered more than ever.
"The work of all vets in government is indispensable in protecting and promoting animal health and welfare and public health, and current UK CVO Nigel Gibbens CBE has been crucial in steering this with calm direction and sage insight from the heart of government.
"We hope to continue our effective working relationship with the new UK CVO, and really look forward the opportunity to work with Christine moving forwards."
Christine will take up her new role as CVO for the UK on the 1 March 2018.
Petplan has launched this year's Insurance Advisor Award in association with VetSurgeon.org, and is calling for nominations.
The award is to recognise the hard work and dedication that Petplan Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially.
Petplan says pet owners often look to vet staff to help them better understand veterinary procedures, treatment and medication, but they're also increasingly looking for advice about insurance, and that is why it is important that a formally trained member of staff is available to answer customer queries when it comes to pet insurance.
Petplan works with over 4,000 veterinary practices throughout the UK to promote pet insurance. These are Appointed Representative (AR) practices who receive training and certification to speak about specific insurance policies. The PIA scheme is an extension of this - AR practice staff can train to become a dedicated Pet Insurance Advisor by registering on www.petplan.co.uk/pia
Becoming a PIA allows vet staff to earn valuable CPD points whilst developing transferable skills such as confidently promoting products and handling client objections.
Deputy Veterinary Practice Manager Kelli Vogt, of Polsloe Veterinary Clinic in Exeter, who won the 'Petplan Insurance Advisor Award 2010', said: "The scheme is such a great programme and I recommend it to all my colleagues and anyone that will listen. It's a great link between veterinary practices and insurers and it means that we can really help pet owners have financial security should anything happen. The more pet owners are informed of the importance of pet insurance the more likely it'll become mandatory, which will allow them to always get the best possible treatment for their pet without having to worry about the financial implications."
Director of Petplan, Neil Brettell said: "We are incredibly proud to help recognise the hard work and dedication that Petplan Insurance Advisors give their customers, helping to keep them constantly informed and up-to-date. So please get your nominations in!"
To nominate your dedicated colleague for the Petplan Insurance Advisor Award, please visit www.petplan.co.uk/pia. The PIA of the Year will receive a 16GB Ipad2 with WiFi, worth £399.
Nominations close on 9th September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress, taking place from Friday 7th - Sunday 9th October 2011.
For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto www.petplanpia.co.uk.
To find out more about Petplan visit http://www.petplan.co.uk/
The urinary products, which are made to provide tailored nutritional solutions for cats and dogs with urinary issues, are available in both wet pouches and dry kibble.
The company simultaneously introduced a new urinary diagnostic tool: the Royal Canin Hematura Detection by Blücare.
The tool is made up of granules which are put in a cat’s litter tray and which turn blue if they detect blood in the urine. Royal Canin says it is a revolutionary diagnostic aid that will be able to prevent feline lower urinary tract disease developing any further.
John O’Connor, Corporate Affairs Director at Royal Canin, said: "We are constantly looking to evolve our offer and provide the very best in nutrition. We have simplified our ranges making it easier to navigate and choose the right product for each cat and dog, created a new premium pack design and developed our best veterinary nutritional solutions.
"It was imperative that we worked very closely with the veterinary community in making this bold transformation so we consulted with vets and vet nurses, in addition to pet owners from across the world."
According to the company, it's the first large-scale EMS online booking system of its type in the veterinary profession and it will mean students can find practice placements at the touch of a button, instead of having to spend time contacting individual surgeries.
With the new system, the 200 CVS practices which currently offer EMS have their own page, where information is provided about the practice, along with a list of available placements.
Once registered, students can search for placements by practice name, location and date.
When a student finds a suitable placement a booking request is triggered, connecting the student to the host practice so that the booking can be confirmed.
CVS has also created a new EMS support framework, based on the RCVS day one competencies, to help practices and students structure each placement.
The company says the new framework puts health, wellbeing and professional skills on a par with clinical skills, to encourage students to take a holistic approach to their development - helping them to grow into happy, competent and confident veterinary surgeons.
Nigel Stansbie, Head of Online Course Creation at CVS, said: “As a major employer within the industry, we are fully committed to supporting the education and development of vet students, by offering high-quality EMS placements, to help them gain the skills and knowledge they will need to thrive when they join the workforce.
“Though we know that there is current debate about the future EMS requirements, we recognise the importance of EMS and are confident that the support we have put in place will enable students to make the most of these valuable work experience opportunties.”
The new CVS EMS online booking system is hosted on the company's knowledge hub: https://www.cvs-knowledgehub.com/.
Tramvetol is presented in two pack sizes of 30 and 100 tablets to assist practices with dispensing and storage as a Schedule 3 controlled drug. The meat flavoured 50mg tablets can also be divided into two equal parts to ensure accurate dosing.
Virbac says Tramvetol is suitable for both short courses and long-term treatment; 2-4mg per kg of Tramvetol can be administered every 8 hours or from 6 hours, if required, based on the intensity of the pain. In addition, Tramvetol has a wide therapeutic window and a maximum daily dose of 16mg per kg.
Commonly used in combination with other forms of analgesia, including NSAIDs1, Tramvetol is quickly absorbed and boats a rapid onset of action2. Peak plasma concentrations are achieved within 45 minutes3.
Dan Johnson, Product Manager at Virbac said: ‘Tramadol is already an important part of the analgesia toolkit for many veterinary practices. We hope that Tramvetol will prove to be a much more convenient option for practices, whilst helping to provide dogs with a better quality, pain free life’.
For more information, contact your Virbac Territory Manager.
When you post a job advert, or a shout for assistance on VetSurgeon Jobs, it is emailed to subscribers immediately and fed out onto other social networks. You can further extend the reach of your post by sharing it yourself and (with "Share and reward") encouraging other members of your team to do likewise.
I have taken the decision to drop the charge for advertising because it seems very clear now that we all face a very grim few months ahead, and it has never been more important that we all pull together and support each other, both personally and in business.
Of course, removing the charge for advertising for help on VetSurgeon.org and VetNurse.co.uk is not, in and of itself, going to save anyone from going under, but I hope perhaps other veterinary suppliers might follow my lead and consider dropping their prices until such time as everyone is back on their feet.
I have a number of other ideas in the pipeline, all designed to help bring the profession together and support each other, which I will announce shortly.
In the meantime, there's a forum discussion for sharing ideas to make the next few months more bearable, here: Getting through coronavirus. Do come and share your thoughts, and I will email the best ideas to all members.
And take care, everyone.
The latest figures from 2017/18 reveal that over 120 million animals were slaughtered in England and Wales without being stunned first1.
In an open letter to Environment Secretary Michael Gove, the BVA and the RSPCA urge the UK Government to change legislation in England which currently allows non-stun slaughter for religious purposes, and provide further public transparency on this issue by releasing the comprehensive 2018 slaughter survey results, which Mr Gove himself signalled would be published by Autumn 2018.
Until such legislation is in place the RSPCA and BVA are calling for:
meat to be labelled with the method of slaughter, e.g. stunned or non-stunned, so consumers are fully informed about the meat that they are buying.
non-stun slaughter to only be permitted at levels that meet local religious community demand for this type of meat in the interests of limiting animal pain and suffering.
a ban on export of meat from non-stunned animals or live animals destined for non-stun slaughter.
an immediate post-cut stun for cattle, sheep, goats and deer to reduce the period of pain and distress.
The letter follows a recent, high profile decision to ban the slaughter of animals without prior stunning in the Flanders region of Belgium which came into force at the start of the year. Belgium joins several other European countries, including Iceland, Sweden, Switzerland and Denmark in making this decision, demonstrating that a full ban on non-stun slaughter is possible within EU law.
RSPCA chief executive, Chris Sherwood said: "Until there is a change in the law to end non-stun slaughter, there are several measures the UK Government could introduce to reduce the suffering involved in this practice. For example, by ensuring trade deals with other countries do not include non-stun meat or live animals for non-stun slaughter, clear labelling should be adopted to enable consumers to make an informed choice about the meat they buy and how it was slaughtered."
BVA President Simon Doherty said: "The UK Government has repeatedly stated it would prefer to see all animals stunned before slaughter but has taken no action to address this critical welfare issue that affects millions of animals every year. It is doubly disappointing that data that would have provided a valuable benchmark for levels of non-stun slaughter in the UK has yet to see the light of day despite assurances throughout last year that it would soon be made public.
"There is a huge groundswell of support for a ban on non-stun slaughter, and recent developments in Belgium show that decisive change is possible where public support is matched by political will. Michael Gove has made clear that he wants to maintain and build on the UK’s reputation as global leader on animal welfare; banning non-stun slaughter is a surefire way of showing he will deliver on this commitment.
"If slaughter without stunning continues to be permitted in the UK, then meat and fish from this source must be clearly labelled, to help customers make informed choices about the food that they buy and eat."
You can sign the open letter at: www.rspca.org.uk/endnonstun and join the online debate using the hashtag #EndNonStun.
Running throughout October, the campaign is designed to raise awareness among dog owners of how Adaptil Calm can help dogs cope during the fireworks and Christmas party season.
The advertising campaign will target 3.3 million pet owners and it will air on over 60 channels including C4 channels (Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home), Sky channels, ITV2 and ITVBe.
Abigail King, behaviour product manager at Ceva Animal Health, said: "The fireworks and party season can be an extremely upsetting time of the year for the nation’s pets.
"By highlighting the benefits of Adaptil at this key time of the year we hope to ensure that dogs are better prepared for the challenges of fireworks and loud noises."
Ceva says the TV advertising campaign will be supported by a digital campaign for both Adaptil and Feliway.
To watch the Adaptil TV advertisement visit https://www.adaptil.com/uk/Success-Stories/Finley.
The procedure was performed in Canada through an international collaboration between partners from Germany, Canada and the UK, who say that this was a case where the placement of the tumour made it impossible to operate without severely impacting the dog’s quality of life. The most suitable treatment was a total excision of the growth and reconstruction with an implant.
The implant was designed with medical CAD tools by German company, Voxelmed, using 3D imaging from the affected area. The dog's veterinary surgeon, Julius Liptak, contributed to the design to ensure it met specifications and allowing him to plan the procedure in advance.
UK company Renishaw then additively manufactured the patient specific implant (PSI) at the Additive Design In Surgical Solutions (ADEISS) Centre in London, Ontario, Canada.
Ed Littlewood, Marketing Manager at Renishaw’s Medical and Dental Products Division said: "Without the advancements in additive manufacturing technology, this dog would not have had such a long and happy future ahead of him.
"Prior to this case, many veterinary surgeons were unaware that the technology was available. Similar procedures are now being planned in Germany and further research is underway to see how animals can benefit from additively manufactured PSIs.
Jan Klasen, veterinary surgeon, 3D designer and CEO of Voxelmed said: "Without AM technology, it would have been almost impossible to reconstruct the dog’s maxilla after tumour removal, because the area was extremely complex in geometry. The implant had to have a similar shape and functionality as the dog’s existing bone structure.
"Using additive manufacturing to maintain the original shape and function of the oral and nasal cavity ensures a high quality of life for the dog, just as a naturally shaped skull and maxilla helps the dog to breathe and eat easily."
To read the full case study, visit http://www.renishaw.com/en/additive-manufacturing-in-veterinary-surgery-saving-a-well-loved-member-of-the-family--42950.
Evidence-Based Veterinary Medicine Matters: Our Commitment to the Future represents the first time that such a broad and influential group has united in support of a single issue in the veterinary profession.
The publication contains a number of case studies which illustrate the impact that evidence can have – and has had – on animal health and welfare. It also provides a rationale for veterinary professionals to contribute to the evidence base and put evidence into practice, to the benefit of animals, owners and veterinary teams themselves.
The signatories to the commitment are:
Animal and Plant Health Agency
British Cattle Veterinary Association
British Equine Veterinary Association
British Small Animal Veterinary Association
British Veterinary Association
British Veterinary Nursing Association
RCVS Knowledge
Royal College of Veterinary Surgeons (RCVS)
Royal Veterinary College
University of Bristol
University of Cambridge
University of Liverpool
University of Nottingham
University of Surrey
Veterinary Policy Research Foundation
No sign of the BAHVS, I see.
Jacqui Molyneux, Chair of the Board of Trustees of RCVS Knowledge, said: "Evidence-Based Veterinary Medicine Matters is a milestone publication for the professions, representing the first time the majority of the key institutions have aligned under the same EBVM banner.
"A celebration of decades of incredible discoveries, achievements and improvements in animal health, it also serves to remind us that even the earliest forms of veterinary medicine were underpinned by evidence."
UK Chief Vet Christine Middlemiss said: "What’s the evidence? An evidence-based approach is vital in all areas of our profession, whatever is keeping you awake at night. For me, it is the threat of African swine fever and avian flu. The evidence I rely on comes from our specialist surveillance monitoring and testing, veterinary epidemiologists and disease modellers. It enables me to make timely, proportionate risk-based decisions that stand up to scrutiny.
"If you are managing veterinary care in practice, the evidence you rely on to underpin your standards of clinical care comes from multiple sources too. Evidence-based veterinary medicine allows us to refine and tailor strategies to be effective and efficient, making full use of existing and new technologies.
"The profession has taken great strides towards embracing evidence-based veterinary medicine and building on this will strengthen the links between clinical decision-making, policy development and future research."
Chris Gush, Executive Director of RCVS Knowledge, added: "We are impressed by the contributions from our co-signatories, which clearly demonstrate the phenomenal impact on patient outcomes that conducting research and using evidence can have. We are also delighted that Sense about Science, a flagbearer for evidence, transparency and rational thinking, has joined with us to highlight the many benefits EBVM can bring.
"The publication also makes a strong case for much-needed funding for research to grow the evidence base, which would put powerful, robust data into the hands of veterinary professionals as they make critical decisions that can affect patient outcomes.
"It is our hope that the calibre, diversity and sheer number of the organisations putting their name to this commitment will galvanise all vets and their teams to expand their use of evidence in practice."
Rebecca Asher, Deputy Director at Sense about Science, said: "This is a showcase of game changers in veterinary care and we hope it will inspire and motivate everyone in the profession.
"We were delighted that RCVS Knowledge approached us to collaborate with them and other leading institutions in the veterinary research community to affirm their commitment to an evidence-based approach to veterinary medicine.
"Everyone expects treatment for humans to be underpinned by evidence. We now expect the same of the whole veterinary community when it comes to the treatment of animals."
The full commitment and portfolio of case studies can be read in Evidence-Based Veterinary Medicine Matters, available for free online: bit.ly/EBVMMatters.
The Mercury Challenge, which is being conducted by Ceva Animal Health, aims to collect data on 10,000 cats across Europe to provide a new insight into the detection and management of feline hypertension, a frequent and severe condition that is still not routinely checked1.
Vets participating in the initiative need to input five mandatory pieces of information at mercurychallenge.ceva.com: the owner’s name, cat’s name, age, systolic blood pressure and time spent measuring blood pressure. Additional information includes: weight, breed, sex and whether the animal has any concurrent diseases, such as chronic kidney disease or hyperthyroidism, or is on any treatments.
Participating practices will be given exclusive access to the study’s progression and results, as well as acknowledgements for their contribution to the Mercury Challenge, depending on the number of cats entered.
Imane Mahlous, cardiology-nephrology and hypertension product manager at Ceva Animal Health said: "It is quick and easy to take part in the Mercury Challenge, which we hope will revolutionise the way that feline hypertension is understood and treated by both cat owners and veterinary professionals."
For information on feline hypertension or the Mercury Challenge, contact your local Ceva Animal Health account manager or visit mercurychallenge.ceva.com.
Mr Seymour-Hamilton was originally removed from the Register following an inspection of his Kent practice in 1993 which found that his operating theatre “showed a total disregard of basic hygiene and care for animals and was such as to bring the profession into disrepute”.
Since being removed from the Register, Mr Seymour-Hamilton has made applications for restoration in 1995, 2010, 2015, 2016, 2017, 2018 and 2019. Each was rejected.
In his latest application, Mr Seymour-Hamilton said that he did not want to re-join the Register in order to practise but to facilitate his research in the area of herbal medicine.
The Committee found that while Mr Seymour-Hamilton had accepted some of the findings of the original case, he disagreed with important facts, such as whether or not his surgery was open at the time of the inspection, and showed ‘minimal insight’ into the seriousness of the findings.
The Committee also voiced concerns over public protection and animal welfare should he be restored, saying that he had demonstrated little or no understanding of the purpose of regulation. The Committee also noted that he had, by his own admission, spayed two cats at a practice in Calais in recent years despite his long absence from the Register and unregistered status as a veterinary surgeon in the UK or France.
In considering his conduct since leaving the Register, the Committee found that Mr Seymour-Hamilton had admitted to a number of instances of conduct which it found ‘reprehensible’. This included carrying out spays; not self-isolating after testing positively for coronavirus and, in fact, travelling through France and Spain in breach of the lockdown put in place due to the pandemic; deliberately trying to re-infect himself with coronavirus and then visiting a vulnerable person without maintaining social distancing; treating his own animals with untested herbal remedies; and using his own remedies to treat people, which, in one case, included a nine-year-old boy in Greece.
In summing up Judith Way, who was chairing the Committee and speaking on its behalf, said: “The Committee has concluded that he has not satisfied it that he is fit to be restored to the Register. He has exhibited a disregard for regulation and compliance with the law. He lacks an understanding as to why he has not been restored in the past. He has not set about addressing any of his shortcomings. He relies wholeheartedly on his research, yet he does not support that research with any real peer-reviewed publications and he fails to acknowledge the consequences of being out-of-practice for so long. He has misplaced confidence in his own abilities and does not recognise that his approach and/or actions can represent a danger to animals and to the public. The Committee has therefore reached the conclusion that the applicant is not a fit person to be restored to the Register.”
The full findings of the restoration hearing for Mr Seymour-Hamilton can be found at: www.rcvs.org.uk/disciplinary
The first charge related to his conviction on two counts of common assault by beating two individuals at an incident in December 2016, as a result of which he was made subject to a community order and a restraining order, as well as being fined and made to pay a victim surcharge and costs.
The second charge related to him undertaking, or attempting to undertake non-emergency surgery on the eyelid of one of the individuals referred to in the first charge, and administering, or attempting to administer, a Prescription-Only Veterinary Medicines to the same person.
The third charged related to an allegation that he had supplied the same individual with a Prescription-Only Medication other than in accordance with a valid prescription.
The second charge and third charges related to incidents which occurred some considerable time before the assault, not as a consequence of it.
At the outset of the hearing Mr Sutcliffe admitted the first and second charges against him and that these constituted serious professional misconduct. He denied the third charge. In relation to that charge the Committee found that, having considered the totality of the evidence, it was unable to be sure that the College had proved the allegation to the requisite standard of proof, namely so that the Committee was sure. Accordingly Charge 3 was dismissed.
The Committee decided that the convictions in the first charge rendered Mr Sutcliffe unfit to practise veterinary surgery and that his conduct in Charge 2 constituted serious professional misconduct.
The Committee then went on to consider sanction.
The Committee considered the aggravating features for both charges. For the first charge it considered the actual injury to one of his victims and risk of injury to the other, noting also that both of his victims were vulnerable people and one was a child, and that the overall incident during which the assaults occurred lasted over a seven hour period.
For the second charge, aggravating factors were that the non-emergency surgery performed by Mr Sutcliffe was wholly inappropriate, that there was a risk of injury to the individual on whom he performed the surgery and that his conduct was reckless.
The mitigating factors considered by the Committee were that Mr Sutcliffe recognised the gravity of the findings against him and demonstrated insight into the allegations, that the incident in charge 1, though prolonged, was an isolated one, that the incident in charge 2 was consensual and did not result in actual harm and that neither charge had any connection with Mr Sutcliffe’s veterinary practice, nor did they affect client care or animal welfare.
Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "As recognised by the Committee, the respondent has displayed insight as to the seriousness of his behaviour. Having regard to the evidence of all the character witnesses and the written testimonials the Committee accepts that the respondent’s conduct as set out in charges 1 and 2 was wholly out of character and, therefore, there is no significant risk of repeat behaviour. The Committee considers that the respondent would be fit to return to practise, having regard to his excellent track record as a veterinary surgeon to date, after any period of suspension.
"Having regards to the aggravating and mitigating factors in this case, the Committee has decided that it is sufficient to maintain public confidence in the profession and declare and uphold proper standards of conduct to give a direction for suspension of the respondent’s name from the Register of Veterinary Surgeons.
"The Committee considers that the period of suspension must be sufficient to mark the seriousness of the charges but must be proportionate and fair in the circumstances of the case. The Committee has therefore concluded that the appropriate period of suspension is six months."
Mr Sutcliffe has 28 days from being informed of the Committee’s decision to appeal to the Privy Council.
This, says the government, would be one of the toughest sanctions in Europe, strengthening the country's claim to be a global leader on animal welfare.
The Animal Welfare (Sentencing) Bill comes after a public consultation held last year which found that more than 70% of people supported proposals for tougher prison sentences. It will allow the courts to take a tougher stance on things like dog fighting, puppy and kitten abuse, and neglect of farm animals.
The new Bill has been welcomed by animal welfare charities.
Chief Executive for the RSPCA, Chris Sherwood, said: "This reform is long overdue. Those responsible for extreme cruelty towards animals or those criminal gangs involved in organised animal crime will now face the tough justice they deserve.
"We need to better protect our animals and the RSPCA hopes that this new Animal Welfare (Sentencing) Bill will give courts the powers they need to punish those responsible for the most unimaginable cruelty to animals.
"We also believe this will act as a much stronger deterrent to others and help us stamp out animal cruelty once and for all."
James Yeates, Cats Protection’s Chief Executive said: "We very much welcome this announcement which is an important step in ensuring the UK is one of the world leaders on animal welfare issues.
Claire Horton, Chief Executive of Battersea Dogs & Cats Home, said: "The introduction of this bill is a landmark achievement, which will make a profound difference to dogs and cats in England and Wales."
Southfields Veterinary Specialists in Laindon, which is part of the Linnaeus Group, has recruited the highly-respected Dr Fabio Stabile to join its neurology and neurosurgery unit.
Fabio will start working at the practice's neurology and neurosurgery unit in January, with another specialist, Dr Ane Uriarte from Tufts University in the USA, joining in the spring.
Fabio said: "I am delighted to be joining Southfields Veterinary Specialists in the new year as a Consultant in neurology and neurosurgery.
"It is an extremely exciting time to be joining Southfields and their team of renowned and successful specialists, especially as this is a strong time of growth in their neurology/neurosurgery discipline.
"The imminent move of the Southfields team to a new, state-of-the-art hospital with the possibility of creating a new phenomenal environment and ‘family’ is really exciting!"
Fabio graduated from Padova University in 2003 before completing a three-year PhD in veterinary clinical sciences at the university supervised by Dr Marco Bernardini DVM, DECVN.
In 2009, he moved to the UK and started a Residency in Neurology and Neurosurgery at the Animal Health Trust under the supervision of Dr Luisa De Risio DVM, FRCVS, PhD, DECVN.
Fabio added: "My main area of interest in veterinary neurology and neurosurgery are epilepsies and the treatment of epilepsy and any neurosurgeries.
"Improving antiepileptic treatment for our patients has constituted my main focus of clinical research. It’s a subject I strongly care about."
Dr Stabile also enjoys passing on the benefits of his expertise and experience to the next generation of veterinary surgeons. He has presented several clinical research abstracts at international and European conferences and he is the author of multiple publications in peer reviewed journal Veterinary Services.
"I have always been extremely keen on teaching and I enjoy delivering lectures to young colleagues in training and to colleagues working in general practice."